SCHEMBL1084535

SCHEMBL1084535

Cc1ccc2c(NC(C3CC3)C3CC3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.51
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
HSP90AA1 P07900 1/20 0.48
CHEK2 O96017 12/20 0.47
CHEK1 O14757 5/20 0.47
AURKA O14965 1/20 0.42
GAA P10253 2/20 0.42
HCRTR1 O43613 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NTRK1 P04629 1/20 0.42
POLB P06746 1/20 0.42
ALK Q9UM73 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13368709 0.85 MAPT (0.59) MAPTMEN1KMT2AHSP90AA1CHEK2
SCHEMBL1084777 0.83 MEN1 (0.67) MEN1KMT2AHSP90AA1CHEK2CHEK1
SCHEMBL1084806 0.82 MAPT (0.53) MAPTMEN1KMT2AHSP90AA1CHEK2
SCHEMBL1084179 0.81 KMT2A (0.55) MAPTMEN1KMT2AHSP90AA1CHEK2
SCHEMBL1084783 0.81 MAPT (0.78) MAPTMEN1KMT2AGAANTRK1
SCHEMBL1084168 0.81 MEN1 (0.71) MEN1KMT2AHSP90AA1CHEK2CHEK1
SCHEMBL1084199 0.81 KMT2A (0.57) MAPTMEN1KMT2AHSP90AA1GAA
SCHEMBL1084656 0.80 MEN1 (0.48) MAPTMEN1KMT2AHSP90AA1CHEK2
SCHEMBL1084416 0.80 MEN1 (0.54) MAPTMEN1KMT2AHSP90AA1CHEK2
SCHEMBL1084760 0.78 KMT2A (0.53) MAPTMEN1KMT2ACHEK2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed